Odyssey Therapeutics

Raised $213M in a Series D round, announced 10 September 2025.

Total raised: $213M

Latest round Series DCountry United StatesSector Health

Round

$213MSeries D, 10 September 2025

Oversubscribed Series D to advance its clinical and preclinical portfolio.

Amount: $213M
Stage: Series D
Announced: 10 September 2025
Lead: Affinity Asset Advisors
Other investors: Dimension Capital, Jeito Capital, Lightspeed Venture Partners, TPG Life Sciences Innovations, Wedbush Healthcare Partners
Use of funds: Oversubscribed Series D to advance its clinical and preclinical portfolio.
Checked: Announced by the company
Sources: Odyssey Therapeutics raises $213M Series D odysseytx.com
Odyssey Therapeutics raises $213M Series D news.crunchbase.com

Company

Clinical-stage developer of medicines for autoimmune and inflammatory diseases

Based in: Boston, United States
Sector: Health
Website: odysseytx.com ↗

Questions

How much has Odyssey Therapeutics raised?

Odyssey Therapeutics raised $213M in a Series D round, announced on 10 September 2025.

Who invested in Odyssey Therapeutics?

Affinity Asset Advisors led. Investors include Affinity Asset Advisors, Dimension Capital, Jeito Capital, Lightspeed Venture Partners, TPG Life Sciences Innovations and Wedbush Healthcare Partners.